Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

copper Cu 64-Tz-SarAr

A radioconjugate composed of a tetrazine-based molecule linked to a SarAr chelator and labeled with the radionuclide copper Cu 64, with potential use as a tracer during positron emission tomography (PET). Upon administration, copper Cu 64-Tz-SarAr binds to the trans-cyclooctene (TCO) moiety of a pre-administered TCO-bearing immunoconjugate, which is bound to an antigen of interest via an antibody moiety. The immunoconjugate localizes the radionuclide to and allows the imaging of target cells expressing the antigen of interest upon PET.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	64Cu-Tz-SarAr

copper Cu 64-Tz-SarAr

Search NCI's Drug Dictionary